Overview / Abstract: |
Educational Objectives - Describe the pathophysiologic underpinnings of severe asthma, including new insights into disease subtypes and therapeutic targets for biologic medications Target Audience Statement of Need/Program Overview Physician Accreditation Statement Physician Credit Designation Global Contact Information Instructions to Receive Credit System Requirements MAC Fee Information & Refund/Cancellation Policy Disclosure of Conflicts of Interest The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity: Linda B. Ford, MD, FACAAI, FAAAAI, AE-C Grant & Research Support from Afferent Pharmaceuticals, Inc., Aimmune Therapeutics, Inc., AstraZeneca plc, Biota Pharmaceuticals, Inc., Circassia Pharmaceuticals plc, Genentech Inc., GlaxoSmithKline plc, F. Hoffman La-Roche AG, Lupin Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Novum Pharmaceutical Research Services, Inc., Pearl Therapeutics Inc., sanofi-aventis U.S. LLC, Zosano Pharma Corporation Neil R. MacIntyre, MD, FCCP Nothing to disclose Michael Wechsler, MD, MMSc Consultant: Ambit Bioscience Corporation, AstraZenecan plc, BSCI, Genentech Inc., GliaCure Inc., Meda Pharmaceuticals Inc., Mylan Specialty L.P., Novartis Pharmacuticals Corporation, Regeneron Pharmaceuticals, Inc., sanofi-aventis U.S. LLC., Sunovion Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Theravance Biopharma U.S. Inc., Tunitas Therapeutics, Inc., Vectura Group plc The following planners and managers reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity: Amanda Glazar, PhD Nothing to disclose Disclosure of Unlabeled Use The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Disclaimer |
Expiration |
Nov 28, 2017 |
Discipline(s) |
Physician CME, Physician Assistant CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
1.0 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Michael E. Wechsler, MD, MMSc; Neil R. MacIntyre, MD, FCCP; Linda B. Ford, MD, FACAAI, FAAAAI, AE-C |
Sponsors / Supporters / Grant Providers |
This activity is jointly provided by Global Education Group and Integritas Communications. |
Keywords / Search Terms |
Integritas Communications Severe Asthma, CME, Free, CE, Integritas Communications Free CE CME |